3.29
Tivic Health Systems Inc Aktie (TIVC) Neueste Nachrichten
Tivic Health Files New Vagus Nerve Stimulation Patent - MPO-mag
Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast - Bluefield Daily Telegraph
Tivic Health Q4 Earnings Preview: Key Financial Results Coming March 21 - StockTitan
Tivic Health Systems, Inc. (NASDAQ:TIVC) Short Interest Down 99.1% in February - Defense World
Tivic Health announces reverse stock split - MSN
Tivic Health stock hits 52-week high at $4.35 amid market fluctuations - Investing.com Canada
Tivic Health Systems Stock Price, Quotes and Forecasts | NASDAQ:TIVC - Benzinga
Tivic Health unveils ncVNS device data for chronic disorders By Investing.com - Investing.com Canada
Tivic Health unveils ncVNS device data for chronic disorders - Investing.com
Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System - Joplin Globe
Can Personalized Vagus Nerve Stimulation Transform Neurological Treatment? New Clinical Data Reveals Key Insights - StockTitan
Tivic Health enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Tivic Health Systems Announces Reverse Stock Split - TipRanks
Tivic Health Systems, Inc. Announces Reverse Stock Split - BioSpace
Tivic Health enacts reverse stock split to meet Nasdaq requirements - Investing.com India
Can Tivic Health's Drastic 1-for-17 Reverse Split Save Its Nasdaq Status? - StockTitan
Breaking down TIVC’s current quarter earnings estimates - US Post News
Tivic Health files patent for personalized VNS device By Investing.com - Investing.com Canada
Tivic Health files patent for personalized VNS device - Investing.com
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - The Bakersfield Californian
Tivic Health Systems, Inc. (NASDAQ:TIVC) Short Interest Up 1,818.2% in February - Defense World
Tivic Health Systems Appoints New COO and President - TipRanks
Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team - Milton Daily Standard
Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now - News & Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist - The Globe and Mail
Tivic Health Systems, Inc. (Nasdaq: TIVC) Makes NASDSAQ Top Gainers List on Licensing News - Investorideas.com newswire
Tivic Health Systems rises after deal for late-stage immunotherapy drug - TradingView
Stock market news: Kindly MD surged by 227.10% while Spire Global plunged by 52.39% during midday trading - Business Upturn
Tivic Health shareholders approve reverse stock split proposal - MSN
Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings - Benzinga
Stock market today: Spire Global plunged by 48.97% while Xilio Therapeutics surged by 102.16% in early trading - Business Upturn
Dow Dips Over 300 Points; US Inflation Increases More Than Expected - Benzinga
Tivic Health Systems Secures Licensing Agreement with Statera - TipRanks
Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist -February 12, 2025 at 08:34 am EST - Marketscreener.com
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
Tivic Health Systems Inc (NASDAQ:TIVC) Up 16.67% Since 52-Week Low; YTD Fall -29.84% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel
Tivic Health shareholders approve reverse stock split proposal By Investing.com - Investing.com South Africa
Enrollment Complete in Tivic Health’s VNS Device Trial - MPO-mag
Tivic Health faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Tivic Health faces potential Nasdaq delisting - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):